Abstract
The development of new drugs is a long and expensive process with multiple sources of uncertainty and complex trade-offs. In this chapter, we discuss how multi-stage stochastic programming (SP) methods can be used to develop tools for decision-making in this sector. First, we present a basic model for the stochastic resource constraint project scheduling problem we consider in this chapter, we discuss extensions for features such as outlicensing and outsourcing, and present modeling methods for risk management. Second, we review theoretical results that allow us to formulate tractable SP models that account for endogenous observation of uncertainty. Finally, we discuss solution methods that allow us to address realistic instances and present two examples.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Andersson F, Mausser H, Rosen D, Uryasev S (2001) Credit risk optimization with conditional value-at-risk criterion. Math Program 89(2):273–291
Birge JR, Louveaux F (1997) Introduction to stochastic programming. Springer, New York
Bottcher J, Drexl A, Kolisch R, Salewski F (1999) Project scheduling under partially renewable resource constraints. Manag Sci 45(4):543–559
Bouleimen K, Lecocq H (2003) A new efficient simulated annealing algorithm for the resource-constrained project scheduling problem and its multiple mode version. Eur J Oper Res 149(2):268–281
Brucker P, Drexl A, Möhring R, Neumann K, Pesch E (1999) Resource-constrained project scheduling: notation, classification, models, and methods. Eur J Oper Res 112(1):3–41
Charalambous C, Gittins JC (2008) Optimal selection policies for a sequence of candidate drugs. Adv Appl Probab 40(2):359–376
Choi J, Realff MJ, Lee JH (2004) Dynamic programming in a heuristically confined state space: a stochastic resource-constrained project scheduling application. Comput Chem Eng 28(6–7): 1039–1058
Colvin M, Maravelias CT (2008) A stochastic programming approach for clinical trial planning in new drug development. Comput Chem Eng 32(11):2626–2642
Colvin M, Maravelias CT (2009) Scheduling of testing tasks and resource planning in new product development using stochastic programming. Comput Chem Eng 33(5):964–976
Colvin M, Maravelias CT (2010) Modeling methods and a branch and cut algorithm for pharmaceutical clinical trial planning using stochastic programming. Eur J Oper Res 203(1):205–215
Colvin M, Maravelias CT (2011) R&D pipeline management: task interdependencies and risk management. Eur J Oper Res 215(3):616–628
De Reyck B, Leus R (2008) R&D project scheduling when activities may fail. IIE Trans 40(4):367–384
DiMasi JA, Grabowski HG (2007) The cost of biopharmaceutical R&D: is biotech different? Manag Decis Econ 28(4–5):469–479
Eppen GD, Martin RK, Schrage L (1989) A scenario approach to capacity planning. Oper Res 37(4):517–527
Gatica G, Papageorgiou LG, Shah N (2003) Capacity planning under uncertainty for the pharmaceutical industry. Chem Eng Res Des 81(A6):665–678
Goel V, Grossmann IE (2004) A stochastic programming approach to planning of offshore gas field developments under uncertainty in reserves. Comput Chem Eng 28(8):1409–1429
Goel V, Grossmann IE (2006) A class of stochastic programs with decision dependent uncertainty. Math Program 108(2–3):355–394
Hartmann S (1998) A competitive genetic algorithm for resource-constrained project scheduling. Nav Res Logist 45(7):733–750
Herroelen W, Leus R (2005) Project scheduling under uncertainty: survey and research potentials. Eur J Oper Res 165(2):289–306
Jain V, Grossmann IE (1999) Resource-constrained scheduling of tests in new product development. Ind Eng Chem Res 38(8):3013–3026
Kall P, Wallace SW (1994) Stochastic programming. Wiley, Chichester
Kolisch R, Hartmann S (2006) Experimental investigation of heuristics for resource-constrained project scheduling: an update. Eur J Oper Res 174(1):23–37
Levis AA, Papageorgiou LG (2004) A hierarchical solution approach for multi-site capacity planning under uncertainty in the pharmaceutical industry. Comput Chem Eng 28(5):707–725
Maravelias CT, Grossmann IE (2004) Optimal resource investment and scheduling of tests for new product development. Comput Chem Eng 28(6–7):1021–1038
Mercier L, Van Hentenryck P (2008) Amsaa: a multistep anticipatory algorithm for online stochastic combinatorial optimization. In: Proceedings of the 5th international conference on integration of AI and OR techniques in constraint programming for combinatorial optimization problems, Paris. LNCS, vol 5015, Springer, New York, pp 173–187
Merkle D, Middendorf M, Schmeck H (2002) Ant colony optimization for resource-constrained project scheduling. IEEE Trans Evol Comput 6(4):333–346
Mika M, Waligóra G, Wȩglarz J (2005) Simulated annealing and tabu search for multi-mode resource-constrained project scheduling with positive discounted cash flows and different payment models. Eur J Oper Res 164(3):639–668
Neumann K, Zimmermann J (2000) Procedures for resource leveling and net present value problems in project scheduling with general temporal and resource constraints. Eur J Oper Res 127(2):425–443
Rockafellar RT, Uryasev S (2002) Conditional value-at-risk for general loss distributions. J Bank Finance 26(7):1443–1471
Rogers MJ, Gupta A, Maranas CD (2002) Real options based analysis of optimal pharmaceutical research and development portfolios. Ind Eng Chem Res 41(25):6607–6620
Schmidt CW, Grossmann IE (1996) Optimization models for the scheduling of testing tasks in new product development. Ind Eng Chem Res 35(10):3498–3510
Schultz R, Tiedemann S (2006) Conditional value-at-risk in stochastic programs with mixed-integer recourse. Math Program 105(2–3):365–386
Shah N (2004) Pharmaceutical supply chains: key issues and strategies for optimisation. Comput Chem Eng 28(6–7):929–941
Solak S, Clarke JPB, Johnson EL, Barnes ER (2010) Optimization of R&D project portfolios under endogenous uncertainty. Eur J Oper Res 207(1):420–433
Souder WE, Mandakovic T (1986) Research-and-development project selection models. Res Manag 29(4):36–42
Steele LW (1988) What we’ve learned: selecting R&D programs and objectives. Res Technol Manag 31(2):17–36
Stonebraker JS (2002) How Bayer makes decisions to develop new drugs. Interfaces 32(6):77–90
Subramanian D, Pekny JF, Reklaitis GV (2001) A simulation-optimization framework for research and development pipeline management. AlChE J 47(10):2226–2242
Subramanian D, Pekny JF, Reklaitis GV, Blau GE (2003) Simulation-optimization framework for stochastic optimization of R&D pipeline management. AlChE J 49(1):96–112
Tormos P, Lova A (2001) A competitive heuristic solution technique for resource-constrained project scheduling. Ann Oper Res 102:65–81
Valls V, Ballestín F, Quintanilla S (2005) Justification and RCPSP: a technique that pays. Eur J Oper Res 165(2):375–386
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Colvin, M., Maravelias, C.T. (2015). Pharmaceutical R&D Pipeline Planning. In: Schwindt, C., Zimmermann, J. (eds) Handbook on Project Management and Scheduling Vol. 2. International Handbooks on Information Systems. Springer, Cham. https://doi.org/10.1007/978-3-319-05915-0_27
Download citation
DOI: https://doi.org/10.1007/978-3-319-05915-0_27
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-05914-3
Online ISBN: 978-3-319-05915-0
eBook Packages: Business and EconomicsBusiness and Management (R0)